Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methyl testosterone vs placebo in poor ovarian responders undergoing IVF
IRCT20091012002576N16Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in poor ovarian response (POR) comparing Methyl testosterone arm with Placebo arm (2 arms). Primary endpoint: IVF outcome. Started Jun 2018; status: completed.
02
Drugs
methyltestosterone
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20091012002576N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N16.